Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Huiyuan Hou

    TitleAssistant Project Scientist
    SchoolUniversity of California, San Diego
    DepartmentOphthalmology
    Address9500 Gilman Drive #0946
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Hou H, Wang C, Nan K, Freeman WR, Sailor MJ, Cheng L. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide. Invest Ophthalmol Vis Sci. 2016 Feb 1; 57(2):557-66. PMID: 26882530.
        View in: PubMed
      2. Hou H, Nieto A, Belghith A, Nan K, Li Y, Freeman WR, Sailor MJ, Cheng L. A sustained intravitreal drug delivery system with remote real time monitoring capability. Acta Biomater. 2015 Sep 15; 24:309-21. PMID: 26087110.
        View in: PubMed
      3. Hou H, Huffman K, Rios S, Freeman WR, Sailor MJ, Cheng L. A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics. Invest Ophthalmol Vis Sci. 2015 Apr 1; 56(4):2755-63. PMID: 25829415.
        View in: PubMed
      4. Nieto A, Hou H, Moon SW, Sailor MJ, Freeman WR, Cheng L. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin. Invest Ophthalmol Vis Sci. 2015; 56(2):1070-80. PMID: 25613937.
        View in: PubMed
      5. Ma F, Nan K, Lee S, Beadle JR, Hou H, Freeman WR, Hostetler KY, Cheng L. Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system. Eur J Pharm Biopharm. 2015 Jan; 89:271-9. PMID: 25513956.
        View in: PubMed
      6. Wang C, Hou H, Nan K, Sailor MJ, Freeman WR, Cheng L. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide. Exp Eye Res. 2014 Dec; 129:74-82. PMID: 25446320.
        View in: PubMed
      7. Nan K, Ma F, Hou H, Freeman WR, Sailor MJ, Cheng L. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin. Acta Biomater. 2014 Aug; 10(8):3505-12. PMID: 24793657.
        View in: PubMed
      8. Barteselli G, Lee SN, El-Emam S, Hou H, Ma F, Chhablani J, Conner L, Cheng L, Bartsch DU, Freeman WR. Macular choroidal volume variations in highly myopic eyes with myopic traction maculopathy and choroidal neovascularization. Retina. 2014 May; 34(5):880-9. PMID: 24217703.
        View in: PubMed
      9. Hou H, Nieto A, Ma F, Freeman WR, Sailor MJ, Cheng L. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon. J Control Release. 2014 Mar 28; 178:46-54. PMID: 24424270.
        View in: PubMed
      10. Nieto A, Hou H, Sailor MJ, Freeman WR, Cheng L. Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles. Exp Eye Res. 2013 Nov; 116:161-8. PMID: 24036388.
        View in: PubMed
      11. Chhablani J, Nieto A, Hou H, Wu EC, Freeman WR, Sailor MJ, Cheng L. Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system. Invest Ophthalmol Vis Sci. 2013 Feb; 54(2):1268-79. PMID: 23322571.
        View in: PubMed